More Articles

AI cardiology heart artificial intelligence deep learning
| Artificial Intelligence

The use of artificial intelligence (AI) to evaluate and treat heart disease has been one of the biggest stories at the…

Newsweek ranked the 50 best heart hospitals in the world
| Policy & Regulations

The International Liaison Committee on Resuscitation (ILCOR), a global group focused on improving patient outcomes after in-hospital cardiac arrest (IHCA), has shared 10 steps hospitals can take to improve the…

QDOT MICRO Biosense Webster Johnson and Johnson
| Heart Rhythm

Treating paroxysmal atrial fibrillation (AFib) with a next-generation radiofrequency (RF) catheter from Biosense Webster, a Johnson and Johnson MedTech company, is associated with significant improvements in quality of life (QOL), according to…

audioplethysmography Google headphones
| Remote Monitoring

Researchers from Google have introduced a new approach for cardiac monitoring that relies on the active noise canceling (ANC) technology found in headphones and earbuds.

The technique, audioplethysmography (APG), can monitor a user’s…

money business cash flow dollar
| Mergers & Acquisitions

Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was…

Medtronic extravascular ICD Aurora EV-ICD MRI SureScan
| Heart Rhythm

Medtronic has gained U.S. Food and Drug Administration (FDA) approval for a new first-of-its-kind extravascular implantable cardioverter-defibrillator (ICD) and defibrillation lead that allows cardiologists to…

SentiAR CommandEP system
| Cardiac Imaging

Augmented reality is becoming more common in healthcare settings, with St. Louis-based developer SentiAR announcing it has received 510(k) clearance from the U.S. Food and Drug…

Specialists at Cleveland Clinic treated a hypertrophic cardiomyopathy patient with a new gene therapy from Tenaya Therapeutics
| Heart Rhythm

Specialists at Cleveland Clinic have treated a hypertrophic cardiomyopathy (HCM) patient with a new gene therapy designed to reverse disease progression.

This represents the first patient to…

| TAVR

Nearly one-fifth of patients die within two years of undergoing transcatheter aortic valve replacement (TAVR), according to a new analysis published in…

Thumbnail
| Electrophysiology

Cardiologists are often not too concerned when atrial arrhythmias occur during the 90-day “blanking period” after catheter ablation. According to a new analysis published in JACC: Clinical Electrophysiology, however, such activity may…

Thumbnail
| TAVR

Cardiologists can safely perform routine electrophysiology (EP) studies during…

Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
| Heart Rhythm

Attune Medical, the Chicago-based healthcare technology company, has received a De Novo approval…

Thumbnail
| TAVR

Non-vitamin K oral anticoagulants (NOACs) are associated with fewer major bleeding events and deaths than vitamin K antagonists (VKAs) when treating patients who develop new-onset atrial fibrillation (AFib) after…

Thumbnail
| Economics

Pharmacy-provided low-cost generic programs (LCGPs) can help improve patient access to affordable cardiovascular disease (CVD) medications. According to a new analysis published in Annals of Internal Medicine, however, coverage varies…

cardiologist preparing to perform radiofrequency ablation
| Electrophysiology

Catheter ablation procedures may help improve the mental health of patients presenting with symptomatic atrial fibrillation (AFib), according to a new analysis published in JAMA.[1] The study’s authors identified key reductions in…

Matthew Latacha, MD, Methodist Health System, cardiologist
| Interventional Cardiology

A bicyclist killed outside Omaha, Nebraska, on the morning of Sept. 10 has been identified as Matthew Latacha, MD, a veteran cardiologist with Methodist Health System. He was 47 years old.

Latacha had…